Todd A. Trapp is President & CFO +1 at ABIOMED INC (NASD). They have made 5 open-market trades across 3 companies since 2018, most recently 2022-12-22.
CIK 0001638242
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NASD | SELL | 2022-11-01 | 2022-11-03 | $378.61 | $732K | N/A | N/A | N/A |
| NASD | SELL | 2022-08-03 | 2022-08-05 | $300.00 | $300K | N/A | N/A | N/A |
| NASD | SELL | 2022-04-04 | 2022-04-06 | $333.00 | $333K | N/A | N/A | N/A |
| ABMD | SELL | 2022-01-05 | 2022-01-07 | $359.43 | $359K | -3.1% | -7.3% | +1.6% |
| WTS | SELL | 2018-02-15 | 2018-02-20 | $75.88 | $681K | -2.3% | +1.2% | +2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.